- BNF:
- Immune System & Malignant Disease
- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- August 2016
Comments
RED:
- NICE TA827: Oral azacitidine for maintenance treatment of acute myeloid leukaemia
after induction therapy. (Decision date - November 2022).
NHS England commissioned - to be used in line with NHSE commissioning intentions.
Do Not Prescribe (DNP):
NICE TA399: for treating acute myeloid leukaemia with more than 30% bone marrow blasts. (Decision date - August 2016).
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
search again
